Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem cerebrospinal fluid pharmacokinetics in neurointensive care patients with extraventricular drainage
2010-020920-24Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doripenem in obstructive hydrocephalus, sponsored by Medical University of Vienna. Primary endpoint: Cerebrospinal fluid and plasma pharmacokinetics of doripenem. Started Oct 2010; status: completed.
02
Drugs
doripenem
03
Conditions
obstructive hydrocephalus
Beyond the preview
Go deeper on 2010-020920-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020920-24.